Preparation method of recombinant collagen hydrogel tissue adhesive for sutureless wound healing
By preparing a recombinant collagen hydrogel tissue adhesive, a dual-network structure is formed by the synergistic effect of various polymers, which solves the shortcomings of existing wound closure devices and achieves rapid, controllable wound healing and biocompatibility, making it suitable for efficient healing of sutureless wounds.
Patent Information
- Application Number
- CN202411388407.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-08
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2044-10-08
AI Technical Summary
Existing wound closure devices such as sutures and staples are time-consuming to operate, have poor appearance and poor tissue integration. Commercially available adhesives have weak adhesion or are toxic under physiological conditions, and lack reliable adhesion, biocompatibility and antibacterial properties.
Using recombinant collagen as the main component, a double-network hydrogel is formed through the enzymatic reaction of carboxymethyl chitosan, polylysine, and glutamine transaminase with Schiff base. The amino and aldehyde groups form reversible Schiff base bonds, which are combined with amide bonds to achieve rapid adhesion and controllable degradation.
It provides a hydrogel tissue adhesive with strong adhesion, antibacterial properties, self-healing ability and controllable biodegradability, which can quickly close deep wounds, replace sutures and staples, and has good biocompatibility and application prospects.
Smart Images

Figure CN119303148B_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of biomaterials technology, specifically relating to a method for preparing a recombinant collagen hydrogel tissue adhesive for sutureless wound healing. Background Technology
[0002] Every year, millions of people suffer from various types of wounds, including those caused by accidental trauma and surgical incisions. Following tissue damage, significant bleeding and wound infection are leading causes of death. Currently, commonly used wound closure devices include staples, sutures, adhesives, sealants, and mechanical devices. Among these, surgical sutures and staples play a crucial role in clinical surgery. However, their drawbacks, such as time-consuming procedures, poor aesthetic results, and suboptimal tissue integration, have rendered them inadequate for meeting the growing demand for wound healing. In recent years, tissue sealants and adhesives have gradually become alternatives to sutures and staples for suturing and sealing wounds or incisions. These materials offer advantages such as minimal invasiveness, low skill requirements, short application time, better tissue integration, and less tissue damage.
[0003] Currently, commercially available adhesives are mainly classified into bio-based adhesives, organic synthetic adhesives, and composite adhesives. Naturally occurring adhesives, such as mussel byssal adhesive protein adhesives and fibrous protein adhesives, have good biocompatibility and biodegradability, but their adhesive performance under physiological conditions is relatively weak because their adhesion mainly relies on relatively weak physical interactions, typically 1 to 10 J / m. 2 Low adhesion. While organic synthetic adhesives such as cyanoacrylate adhesives have higher adhesion properties, the toxicity of cyanoacrylate limits their clinical application within tissues.
[0004] Therefore, there is still a need for better tissue adhesives that not only have reliable adhesive properties but also good biocompatibility, biodegradability, hemostatic and antibacterial activity, as a convenient option for trauma first aid and surgical incision adhesion. Summary of the Invention
[0005] The technical problem this invention aims to solve is to address the shortcomings of the prior art by providing a method for preparing a recombinant collagen hydrogel tissue adhesive for sutureless wound healing. This method uses recombinant collagen as the main component and leverages the synergistic effects between various polymers to achieve rapid hydrogel formation with excellent adhesion, antibacterial properties, and the ability to promote collagen deposition and controllable biodegradation in wounds. The prepared dual-network hydrogel tissue adhesive can be injected into deep wounds, replacing sutures and staples in wound closure, and shows promising application prospects.
[0006] To solve the above-mentioned technical problems, the technical solution adopted by the present invention is: a method for preparing a recombinant collagen hydrogel tissue adhesive for sutureless wound healing, characterized by comprising the following steps:
[0007] Step 1: At room temperature, dissolve carboxymethyl chitosan and polylysine in deionized water to obtain a mixed solution. Adjust the pH of the mixed solution to neutral, and then add transglutaminase to the mixed solution to obtain solution A.
[0008] Step 2: Dissolve the recombinant collagen and the four-armed polyethylene glycol aldehyde group in deionized water to obtain solution B;
[0009] Step 3: Mix liquid A from step 1 and liquid B from step 2 evenly to obtain a recombinant collagen hydrogel tissue adhesive for sutureless wound healing.
[0010] The method for preparing the above-mentioned recombinant collagen hydrogel tissue adhesive for sutureless wound healing is characterized in that the mass percentage of carboxymethyl chitosan and the mass percentage of polylysine in the mixed solution in step one is 8.4% to 12%.
[0011] The preparation method of the above-mentioned recombinant collagen hydrogel tissue adhesive for sutureless wound healing is characterized in that, in step one, the amount of transglutaminase is adjusted according to the quality of the recombinant collagen, and the amount of transglutaminase used per gram of recombinant collagen is not less than 0.08g.
[0012] The preparation method of the above-mentioned recombinant collagen hydrogel tissue adhesive for sutureless wound healing is characterized in that the content of recombinant collagen in solution B in step two is adjusted according to the time required for wound healing, the mass percentage of recombinant collagen is not less than 8%, and the mass percentage of tetra-arm-polyethylene glycol-aldehyde group is 8% to 12%.
[0013] The method for preparing the above-mentioned recombinant collagen hydrogel tissue adhesive for sutureless wound healing is characterized in that the mass percentage of recombinant collagen in solution B is 8% to 15%.
[0014] The preparation method of the above-mentioned recombinant collagen hydrogel tissue adhesive for sutureless wound healing is characterized in that the recombinant collagen in step two is CF-1552I type recombinant collagen, and the molecular weight of the four-arm polyethylene glycol-aldehyde group is 10000.
[0015] The method for preparing the recombinant collagen hydrogel tissue adhesive for sutureless wound healing described above is characterized in that the volume ratio of liquid A to liquid B in step three is 1:1.
[0016] The preparation method of the above-mentioned recombinant collagen hydrogel tissue adhesive for sutureless wound healing is characterized in that, in step three, liquid A and liquid B are mixed evenly using a three-way valve and a syringe.
[0017] Compared with the prior art, the present invention has the following advantages:
[0018] 1. This invention utilizes recombinant collagen (especially CF-1552Ⅰ type recombinant collagen from the Institute of Biomedical Research, School of Chemical Engineering, Northwest University, which contains a large amount of glutamine) to form amide bonds with polylysine (EPL) through an enzymatic reaction. Through the formation of a double network, while retaining its low immunogenicity, it endows the adhesive with advantages such as strong adhesion, antibacterial properties, self-healing properties, injectability, and controllable biodegradability, which are different from other protein adhesives.
[0019] 2. This invention utilizes a combination of transglutaminase (TG enzyme)-mediated enzymatic reaction and Schiff base reaction to rapidly form a wound-adaptive tissue adhesive through a first network and endow it with certain mechanical properties. Then, a second network enhances its adhesive properties and controls its degradation rate. The resulting dual-network structure solves the shortcomings of single-network collagen, such as long gelation time, poor mechanical properties, lack of fatigue toughness, excessive swelling, and excessively fast degradation rate, as well as the instability, poor adhesion, flexibility, and toughness of single-network Schiff base collagen.
[0020] 3. This invention is the first to utilize carboxymethyl chitosan (CMCS) and polylysine (EPL) together to provide an amino-based synthetic hydrogel adhesive. By leveraging the synergistic effect of CMCS and EPL, the drawbacks of non-adhesive hydrogels formed by CMCS and aldehyde groups and the long gelation time of hydrogels formed by EPL and aldehyde groups are overcome.
[0021] 4. This invention uses a four-armed polyethylene glycol-aldehyde group as a polymer to provide a large number of aldehyde groups for the formation of the hydrogel Schiff base network, which form reversible Schiff base bonds with amino groups to give the hydrogel injectability and self-healing properties, while enhancing the adhesion of the hydrogel to tissues.
[0022] 5. The present invention preferably uses a three-way valve and a syringe to mix solution A and solution B, which can quickly mix the two solutions evenly and achieve injectability of the tissue adhesive by connecting the syringe to the three-way valve, so as to achieve a better effect of closing deep wounds.
[0023] 6. The preparation method of the present invention is simple, requires no chemical cross-linking agent, and the prepared recombinant collagen hydrogel tissue adhesive has high biological compatibility and good reproducibility. It can tightly bond wounds and has the advantages of strong adhesion, strong antibacterial ability and low immunogenicity. It can replace sutures and staples to promote the repair of deep wounds caused by surgical incisions and accidental trauma, and has good application prospects.
[0024] The technical solution of the present invention will be further described in detail below with reference to the accompanying drawings and embodiments. Attached Figure Description
[0025] Figure 1 This is a schematic flowchart of the method for preparing hydrogel tissue adhesive according to the present invention.
[0026] Figure 2 This is a diagram showing the appearance of liquid A and liquid B of the present invention, as well as the mixture of the two at room temperature.
[0027] Figure 3 The FTIR spectra of each network in the hydrogel tissue adhesive prepared in this invention are shown.
[0028] Figure 4 SEM images of each network in the hydrogel tissue adhesive prepared in this invention.
[0029] Figure 5 The adhesion performance test results are for the hydrogel tissue adhesive prepared in this invention.
[0030] Figure 6 The results of the self-healing test of the hydrogel tissue adhesive prepared in this invention are shown.
[0031] Figure 7 The injectability test results are for the hydrogel tissue adhesive prepared in this invention.
[0032] Figure 8 The results of cytotoxicity tests on the hydrogel tissue adhesive prepared in this invention are shown.
[0033] Figure 9 The antibacterial test results are for the hydrogel tissue adhesive prepared according to the present invention.
[0034] Figure 10 The results of wound closure and healing tests on the hydrogel tissue adhesive prepared in this invention are shown. Detailed Implementation
[0035] To make the above-mentioned objects, features and advantages of the present invention more apparent and understandable, the specific embodiments of the present invention will be described in detail below with reference to examples. In the following examples, the molecular weight of carboxymethyl chitosan was 544, and the molecular weight of polylysine was 2000-5000, both purchased from Aladdin; the enzyme activity of transglutaminase (TG enzyme) was 1000 u / g, purchased from Solarbio; the recombinant collagen was CF-1552I type recombinant collagen, obtained from the Institute of Biomedical Research, School of Chemical Engineering, Northwest University. CF-1552I type recombinant collagen was derived by reverse transcription of human collagen mRNA to generate cDNA, which was then expressed in Escherichia coli BL21. Its structure and acquisition method can be referred to the patent application document with patent number ZL01106757.8, entitled "A Human-like Collagen and Its Production Method", or the literature Recombinant collagen for therepair of skin wounds and photo-aging damage, Regenerative Biomaterials, 2024, 11, rbae108; the molecular weight of the four-armed polyethylene glycol-aldehyde group was 10000, purchased from Maclean's. Unless otherwise specified, all reagents used in the description of this invention are commercially available.
[0036] The preparation method of the recombinant collagen hydrogel tissue adhesive for sutureless wound healing of the present invention is as follows: Figure 1 As shown, the specific steps include:
[0037] Step 1: At room temperature, dissolve carboxymethyl chitosan and polylysine in deionized water to obtain a mixed solution. Adjust the pH of the mixed solution to neutral, and then add transglutaminase to the mixed solution to obtain solution A. The mass percentage of carboxymethyl chitosan in the mixed solution is 8.5%–12%, and the mass percentage of polylysine is 6.7%–9.5%. Adjust the amount of transglutaminase according to the mass of recombinant collagen in Step 2, with no less than 0.08g of transglutaminase per gram of recombinant collagen.
[0038] Step 2: Dissolve recombinant collagen and tetra-arm-polyethylene glycol-aldehyde group in deionized water to obtain solution B; the content of recombinant collagen in solution B is adjusted according to the wound healing time, the mass percentage of recombinant collagen is not less than 8%, preferably 8% to 15%, and the mass percentage of tetra-arm-polyethylene glycol-aldehyde group is 8% to 12%.
[0039] Step 3: Using a three-way valve and a syringe, mix solution A from Step 1 and solution B from Step 2 at a 1:1 volume ratio to obtain a recombinant collagen hydrogel tissue adhesive for sutureless wound healing. The first network of the hydrogel tissue adhesive is formed within ten seconds using reversible Schiff base bonds created by amino and aldehyde groups. Then, the second network of the hydrogel tissue adhesive is formed by the slow formation of amide bonds between glutamine and amino groups through the action of transglutaminase.
[0040] Example 1
[0041] The preparation method of the recombinant collagen hydrogel tissue adhesive for sutureless wound healing in this embodiment specifically includes the following steps:
[0042] Step 1: At room temperature, dissolve 0.10g carboxymethyl chitosan and 0.08g polylysine in 1mL of deionized water and stir at 400rpm for 2h to dissolve them and obtain a mixed solution. Adjust the pH of the mixed solution to neutral, and then add 0.008g TG enzyme (transglutaminase) to the mixed solution and mix to obtain solution A.
[0043] Step 2: Dissolve 0.1g of recombinant collagen and 0.10g of tetra-armed polyethylene glycol-aldehyde in 1mL of deionized water, and adjust the pH to neutral to obtain solution B;
[0044] Step 3: Using a three-way valve and a syringe, mix liquid A from step 1 and liquid B from step 2 at a volume ratio of 1:1 to obtain a recombinant collagen hydrogel tissue adhesive for sutureless wound healing.
[0045] Example 2
[0046] The preparation method of the recombinant collagen hydrogel tissue adhesive for sutureless wound healing in this embodiment specifically includes the following steps:
[0047] Step 1: At room temperature, dissolve 0.12g of carboxymethyl chitosan and 0.09g of polylysine in 1mL of deionized water and stir at 300rpm for 2 hours to dissolve them and obtain a mixed solution. Adjust the pH of the mixed solution to neutral, and then add 0.008g of TG enzyme to the mixed solution and mix to obtain solution A.
[0048] Step 2: Dissolve 0.1g of recombinant collagen and 0.12g of four-arm polyethylene glycol-aldehyde in 1mL of deionized water, and adjust the pH to neutral to obtain solution B;
[0049] Step 3: Using a three-way valve and a syringe, mix liquid A from step 1 and liquid B from step 2 at a volume ratio of 1:1 to obtain a recombinant collagen hydrogel tissue adhesive for sutureless wound healing.
[0050] Example 3
[0051] The preparation method of the recombinant collagen hydrogel tissue adhesive for sutureless wound healing in this embodiment specifically includes the following steps:
[0052] Step 1: At room temperature, dissolve 0.15g of carboxymethyl chitosan and 0.10g of polylysine in 1mL of deionized water and stir at 200rpm for 3h to dissolve them and obtain a mixed solution. Adjust the pH of the mixed solution to neutral, and then add 0.01g of TG enzyme to the mixed solution and mix to obtain solution A.
[0053] Step 2: Dissolve 0.1g of recombinant collagen and 0.12g of four-arm polyethylene glycol-aldehyde in 1mL of deionized water, and adjust the pH to neutral to obtain solution B;
[0054] Step 3: Using a three-way valve and a syringe, mix liquid A from step 1 and liquid B from step 2 at a volume ratio of 1:1 to obtain a recombinant collagen hydrogel tissue adhesive for sutureless wound healing.
[0055] Example 4
[0056] The preparation method of the recombinant collagen hydrogel tissue adhesive for sutureless wound healing in this embodiment specifically includes the following steps:
[0057] Step 1: At room temperature, dissolve 0.12g of carboxymethyl chitosan and 0.10g of polylysine in 1mL of deionized water and stir at 200rpm for 3h to dissolve them and obtain a mixed solution. Adjust the pH of the mixed solution to neutral, and then add 0.008g of TG enzyme to the mixed solution and mix to obtain solution A.
[0058] Step 2: Dissolve 0.1g of recombinant collagen and 0.15g of tetra-armed polyethylene glycol-aldehyde in 1mL of deionized water, and adjust the pH to neutral to obtain solution B;
[0059] Step 3: Using a three-way valve and a syringe, mix liquid A from step 1 and liquid B from step 2 at a volume ratio of 1:1 to obtain a recombinant collagen hydrogel tissue adhesive for sutureless wound healing.
[0060] Example 5
[0061] The preparation method of the recombinant collagen hydrogel tissue adhesive for sutureless wound healing in this embodiment specifically includes the following steps:
[0062] Step 1: At room temperature, dissolve 0.15g carboxymethyl chitosan and 0.12g polylysine in 1mL of deionized water and stir at 200rpm for 3h to dissolve them and obtain a mixed solution. Adjust the pH of the mixed solution to neutral, and then add 0.016g TG enzyme to the mixed solution and mix to obtain solution A.
[0063] Step 2: Dissolve 0.2g of recombinant collagen and 0.15g of tetra-armed polyethylene glycol-aldehyde in 1mL of deionized water, and adjust the pH to neutral to obtain solution B;
[0064] Step 3: Using a three-way valve and a syringe, mix liquid A from step 1 and liquid B from step 2 at a volume ratio of 1:1 to obtain a recombinant collagen hydrogel tissue adhesive for sutureless wound healing.
[0065] Performance evaluation:
[0066] Solutions A and B were added to a small vial, mixed thoroughly, and then inverted to observe the formation of a hydrogel. Results are shown below. Figure 2 As can be seen from the figure, the two liquids can change from a liquid state to a gel state at room temperature after being mixed evenly.
[0067] The infrared absorption spectra of lyophilized hydrogel tissue adhesive samples were measured using Fourier transform infrared spectroscopy (FT-IR). The test conditions were as follows: test resolution was 4 cm⁻¹. -1 The number of scans was 32, and the test wavenumber range was 400–4000 cm⁻¹. -1 The results are shown below. Figure 3 As can be seen from the figure, PEG-EPL / CMCS has a growth rate of 1690–1640 cm⁻¹ -1 EPL-CF exhibits weak infrared absorption at (C=N), while it shows strong absorption at 1670 cm⁻¹. -1 An absorption peak is shown at C=O bond, and at 3430 cm⁻¹. -1 The absorption peak at the NH (amide bond) is visible. The infrared spectrum of PEG-EPL / CMCS-CF shows the absorption peaks of PEG-EPL and EPL-CF in the range of 1660–1690 cm⁻¹. -1 and 3240cm -1 The two characteristic peaks at the point, namely amide and imine, indicate that both networks have been formed.
[0068] The freeze-dried hydrogel tissue adhesive was cut into samples approximately 2 mm thick, adhered to the sample stage with conductive adhesive, and then sputtered with gold using a particle sputtering instrument. The microstructure was then observed using a scanning electron microscope (SEM). Results are shown below. Figure 4 As can be seen from the figure, the hydrogel tissue adhesive has a porous three-dimensional spatial network, and the pores are smaller than those of the Schiff base mono-network hydrogel.
[0069] The adhesion properties of the hydrogel tissue adhesives prepared in Examples 1, 4, and 5 of this invention were tested using a universal material compressor. Before each test, 1 mL of the hydrogel tissue adhesive was injected onto pigskin (50 mm long, 5 mm wide, and 2 mm thick), and an overlap shear test was performed at a test rate of 1 mm / min to detect adhesion properties. The compressive strength of the hydrogel was also analyzed. The hydrogel was prepared in a cylindrical mold (10 mm in diameter and 5 mm in height). The compression rate was 1 mm / min. Each test was repeated at least three times. For the cyclic compression test, the cylindrical hydrogel (10 mm in diameter and 5 mm in height) was cyclically compressed to 50% of its strain and returned to its initial height. The results are shown in […]. Figure 5 As shown in the figure, the adhesion strength between the hydrogel and pigskin increases with the increase of the aldehyde group ratio in the hydrogel system, reaching a maximum of 58.7 kPa. Furthermore, the hydrogel can adhere tightly to various tissues, including the liver, heart, and kidneys, achieving robust incision closure.
[0070] According to the method of this invention, two different colored hydrogel tissue adhesives were prepared using dyes. The hydrogels were cut along a line of symmetry using a sterile scalpel, and then the two different colored hydrogels were aligned along the incision. After a period of time, their self-healing properties were observed by stretching. Results are shown below. Figure 6 As can be seen from the figure, due to the reversibility of the Schiff base bond formed between the aldehyde and amino groups, the hydrogel can maintain its integrity under gravity and can be stretched like a complete hydrogel.
[0071] Rotational rheology was used to evaluate the rheological properties of the hydrogel at room temperature. Prepared hydrogel tissue adhesive samples were placed on the rotary rheometer frustum, and the injectability of the PEG-EPL-CF hydrogel was tested by strain scanning rheology. Furthermore, the self-healing properties of the hydrogel were evaluated at the microscopic level through stepwise strain rheological tests between 5% and 500% strain. Strain scanning was performed on the pre-gelated solution to verify the linear response. The gel point was determined as the time when the torsional modulus (G′) exceeded the loss modulus (G″). Oscillatory rheological measurements were performed under linear viscoelastic conditions at 37°C. Results are shown below. Figure 7 As can be seen from the figure, when a strain of 318% is applied to the hydrogel tissue adhesive, its internal network collapses, exhibiting a viscous liquid state, indicating that the hydrogel tissue adhesive of the present invention is injectable.
[0072] To determine the in vitro cell compatibility of the hydrogel tissue adhesive, the hydrogel was co-cultured with cell culture medium for 12 h, and then 10 5 100 μL of L929 cell suspension per mL was added to a 96-well plate. After 12 h, the culture medium was aspirated and 100 μL of hydrogel extraction buffer was added for incubation. After 24, 48, and 72 h, 10 μL of CCK-8 solution was added. After incubation at 37 °C in the dark for 2 h, the absorbance value was recorded at 450 nm using a microplate reader.
[0073]
[0074] OD sample: Culture medium containing cells, CCK8, and toxic substances; OD control: Culture medium containing cells, CCK8, and no toxic substances; OD blank: Culture medium without cells and toxic substances, and CCK8. Results are shown below. Figure 8 The results showed that the hydrogel tissue adhesive of the present invention had a cytotoxicity of less than 80% and good biocompatibility.
[0075] To evaluate the antibacterial properties of the hydrogel tissue adhesive, 100 μL of 10 6 A bacterial suspension of CFU / mL was spread on a plate for use in the inhibition zone test. A hydrogel tissue adhesive was placed at the bottom of the test tube, followed by the bacterial suspension (10... 6 CFU / mL was added to the hydrogel tissue adhesive at different volume percentages (10%, 20%, 30%). The tubes were incubated at 37°C for 12 hours. After imaging, the supernatant was transferred to a 96-well plate, and the OD value at 600 nm was measured using a microplate reader (with samples without hydrogel as a control). Simultaneously, the co-cultured bacterial culture was spread, and the sterilization rate was calculated based on the colony count after 12 hours. Results are shown below. Figure 9 The results showed that the hydrogel tissue adhesive of the present invention has good antibacterial effect. The hydrogel tissue adhesive has a bactericidal rate of >99.9% against MBCs of Staphylococcus aureus and Escherichia coli of 20% (v / v) and 30% (v / v), respectively.
[0076] To further investigate the potential of hydrogels for wound closure, a full-thickness skin incision model was used in SD rats (male, incision length = 2 cm). Solutions A and B were mixed thoroughly and injected into the incision, which was then held in place for 2 minutes. Surgical sutures, cyanoacrylate adhesive, and Schiff base monolayer hydrogel were compared. Results are shown below. Figure 10The results showed that the hydrogel tissue adhesive of the present invention has a good wound-sealing effect. The dual-network hydrogel group can promote collagen deposition at the wound site and heals faster than the Schiff base single-network hydrogel group. In contrast, the suture group heals slower and is prone to inflammation, while cyanoacrylate glue is brittle and the incision is prone to secondary dehiscence.
[0077] The above description is merely a preferred embodiment of the present invention and does not constitute any limitation on the present invention. Any simple modifications, alterations, or equivalent structural changes made to the above embodiments based on the technical essence of the invention shall still fall within the protection scope of the present invention.
Claims
1. A method for the preparation of a recombinant collagen hydrogel tissue adhesive for sutureless wound healing, characterized in that, Includes the following steps: Step 1: At room temperature, dissolve carboxymethyl chitosan and polylysine in deionized water to obtain a mixed solution. Adjust the pH of the mixed solution to neutral, and then add transglutaminase to the mixed solution to obtain solution A. Adjust the amount of transglutaminase according to the quality of recombinant collagen, with no less than 0.08g of transglutaminase per gram of recombinant collagen. Step 2: Dissolve the recombinant collagen and the four-armed polyethylene glycol aldehyde group in deionized water to obtain solution B; Step 3: Mix liquid A from step 1 and liquid B from step 2 evenly to obtain a recombinant collagen hydrogel tissue adhesive for sutureless wound healing.
2. The method for preparing the recombinant collagen hydrogel tissue adhesive for sutureless wound healing according to claim 1, characterized in that, The mixed solution in step one contains 8.4% to 12% carboxymethyl chitosan by mass and 6.7% to 9.5% polylysine by mass.
3. The method for preparing the recombinant collagen hydrogel tissue adhesive for sutureless wound healing according to claim 1, characterized in that, The content of recombinant collagen in solution B in step two is adjusted according to the time required for wound healing. The mass percentage of recombinant collagen is not less than 8%, and the mass percentage of tetra-polyethylene glycol-aldehyde groups is 8%~12%.
4. The method for preparing the recombinant collagen hydrogel tissue adhesive for sutureless wound healing according to claim 3, characterized in that, The recombinant collagen in solution B contains 8% to 15% by mass.
5. The method for preparing the recombinant collagen hydrogel tissue adhesive for sutureless wound healing according to claim 1, characterized in that, The recombinant collagen mentioned in step two is CF-1552 type I recombinant collagen, and the molecular weight of the four-arm polyethylene glycol-aldehyde group is 10,000.
6. The method for preparing the recombinant collagen hydrogel tissue adhesive for sutureless wound healing according to claim 1, characterized in that, In step three, the volume ratio of liquid A to liquid B is 1:
1.
7. The method for preparing the recombinant collagen hydrogel tissue adhesive for sutureless wound healing according to claim 1, characterized in that, In step three, liquid A and liquid B are mixed evenly using a three-way valve and a syringe.
Citation Information
Patent Citations
Human like collagen and production method thereof
CN1371919A
Injectable antibacterial hemostatic hydrogel adhesive and preparation method and application thereof
CN111840631A
Dual-network adhesive for crosslinking of transglutaminase and preparation method of dual-network adhesive
CN112494710A
Dual-network fibrin gel as well as preparation method and application thereof
CN115785478A
